Not registered yet? Get a free account.

Sign Up
search icon cancel icon

GLAXOSMITHKLINE ASIA PRIVATE LIMITED

www.gsk-india.com
Active
Updated: 21 Oct 2024

Glaxosmithkline Asia Private Limited, is an unlisted private company incorporated on 18 October, 1995. It is classified as a private limited company and is located in Patiala, Punjab. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 5.50 cr.

Glaxosmithkline Asia's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 7.51% over the previous year. At the same time, it's book networth has decreased by 16.22%.

Read more

Industry

Community, Personal and Social Services
Products
  • Paracetamol Tablet, Sumo Cold Medicine, Vitamin Tablet, Cetirizine Tablet, Paracetamol Syrup, Combiflam
Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales
18.16%
₹ 2,757.9
EBITDA
48.96%
₹ 633.4
Net Profit
48.13%
₹ 478.1
Networth
-5.13%
₹ 1,843.3
Borrowings
-
₹ -
Assets
4.37%
₹ 3,055.9
Gross Margin
0.4
79.3 %
Operating Margin
4.75
23.0 %
Net Profit Margin
3.47
17.1 %
Return on Equity
9.33
25.9 %
ROCE
11.35
32.2 %
Debt to Equity
-
0.0
Sales
Mar 2024
Net worth
Mar 2024

Locations

indian flag India (26)
State Type Address

location icon Locations on Map

Map placeholder

Tofler Score

Very Good
score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Financial Highlights

** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales 1,668.8 1,693.9 1,949.5 2,334.1 2,757.9
Operating profit 343.8 445.9 459.7 425.2 633.4
Net profit 470.9 437.7 402.7 322.7 478.1
Gross margin 80.5 82.6 81.8 79.0 79.3
Operating margin 20.6 26.3 23.6 18.2 23.0
Net margin 23.7 23.9 19.7 13.7 17.1
Networth 1,479.9 1,917.1 2,319.0 1,942.9 1,843.3
Borrowings - - - - -
Assets 1,992.2 2,527.2 3,131.7 2,927.9 3,055.9
Debt to equity 0.0 0.0 0.0 0.0 0.0
Current ratio 4.0 4.3 1.7 1.3 1.2
ROE 31.8 22.8 17.4 16.6 25.9
Days payable 295.0 539.0 584.0 486.0 456.0
WC days 283.0 390.0 90.0 33.0 21.0
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

Standalone
Consolidated
%
** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 5.5 5.5 5.5 5.5 5.5
Reserves 1,474.4 1,911.6 2,313.5 1,937.4 1,837.8
Borrowings + - - - - -
Long term borrowings - - - - -
Short term borrowings - - - - -
Trade payables + 263.4 435.4 568.8 653.5 711.8
Days payable 295.0 539.0 584.0 486.0 456.0
Other liabilities + 512.3 610.0 812.7 985.0 1,212.6
Other non-current liabilities 80.7 63.4 131.4 204.7 272.2
Other current liabilities 168.2 111.2 112.5 126.9 228.6
Total liabilities 1,992.2 2,527.2 3,131.7 2,927.9 3,055.9
Fixed Assets + 31.5 4.3 1,703.9 1,756.5 1,756.9
Tangible assets 31.4 4.3 9.7 68.9 67.8
CWIP 0.1 - 8.6 1.6 2.9
Intangible assets - - 1,685.6 1,685.9 1,686.2
LT loans and advances 1.2 0.8 0.7 0.6 1.0
Other non-current assets 234.6 164.1 263.2 177.0 201.9
Current assets + 1,724.8 2,357.9 1,163.9 993.9 1,096.2
Inventories 61.0 66.6 79.5 97.2 127.5
Trade receivables 5.8 176.1 137.6 150.6 235.4
Cash and cash equivalents 1,426.5 629.2 548.7 492.6 423.5
ST loans and advances 1.3 1.1 1.1 0.6 0.7
Other current assets 230.3 1,484.9 396.9 252.9 309.0
Total assets 1,992.2 2,527.2 3,131.7 2,927.9 3,055.9
chart icon

Total assets

Profit & Loss

Standalone
Consolidated
%
** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales + 1,668.8 1,693.9 1,949.5 2,334.1 2,757.9
Sales growth % 9.16 1.5 15.09 19.73 18.16
Expenses + 1,353.0 1,254.0 1,500.5 1,927.7 2,146.6
Cost of goods 325.9 294.7 355.4 491.3 569.4
Employee cost 209.8 123.6 158.6 161.3 253.2
Other costs 789.3 829.7 975.8 1,256.3 1,301.9
Operating profit + 343.8 445.9 459.7 425.2 633.4
Operating margin % 20.6 26.3 23.6 18.2 23.0
Other income 315.1 69.5 93.0 27.5 31.2
Interest 6.3 0.9 2.7 4.6 4.7
Depreciation 21.8 5.2 8.1 14.2 17.4
Exceptional items - - - - -
Profit before tax 630.9 509.3 541.9 433.9 642.5
Tax 160.0 138.4 139.2 111.2 164.4
Profit - disc. ops - 66.7 - - -
Net profit 470.9 437.7 402.7 322.7 478.1
Net margin % 23.7 23.9 19.7 13.7 17.1
chart icon

Revenue from operations

Ratios

Standalone
Consolidated
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Solvency +
Total Debt/Equity 0.0 0.0 0.0 0.0 0.0
Net Debt/Equity 0.0 0.0 0.0 0.0 0.0
Total Debt/Assets 0.0 0.0 0.0 0.0 0.0
Total Assets/Equity 1.4 1.3 1.4 1.5 1.7
Liquidity +
Current Ratio 4.0 4.3 1.7 1.3 1.2
Quick Ratio 3.9 4.2 1.6 1.1 1.0
Interest Coverage 54.8 523.3 170.4 92.8 134.2
Performance
Gross Margin 80.5 82.6 81.8 79.0 79.3
Operating Margin 20.6 26.3 23.6 18.2 23.0
Net Margin 23.7 23.9 19.7 13.7 17.1
Return +
Return on Equity 31.8 22.8 17.4 16.6 25.9
Pre-tax ROCE 24.3 24.3 20.7 20.9 32.2
Return on Assets 23.6 17.3 12.9 11.0 15.6
Pre-tax ROIC 21.8 23.0 19.5 21.1 33.4
Efficiency +
Days Payable 295.0 539.0 584.0 486.0 456.0
Days Inventory 68.0 83.0 82.0 72.0 82.0
Days Receivable 1.0 38.0 26.0 24.0 31.0
Fixed Asset Turnover 52.9 390.2 1.1 1.3 1.6
Total Asset Turnover 0.8 0.7 0.6 0.8 0.9
Working Capital
Cash Conversion Cycle -226.0 -418.0 -476.0 -390.0 -343.0
Working Capital Days 283.0 390.0 90.0 33.0 21.0
chart icon

Ratios

Current ratio
Debt/equity ratio

Charges on assets

As per information available, the company has no registered charges.

People

Designation Name DIN/PAN Tenure
Director Ramesh Chander Gupta 02314913 17 years
Whole-time Director Anurita Chopra 07607315 9 years
Whole-time Director Kanika Shah Wadhwa 08386613 6 years
Whole-time Director Nitin Mathur 09046346 4 years

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address

Subsidiary Companies

Name State / Country Incorporation Year Paidup Capital
Chiron Behring Vaccines Private Limited India - -

Registered Details

CIN

U99999PB1995PTC028476

PAN

AABCS3237R

Incorporation

1995, 29.5 years

Company Email

kanika.x.shahwadhwa@haleon.com

Paid up Capital

₹ 5.5 Cr

Authorised Capital

₹ 10.0 Cr

AGM

Sep 2023

Type

Private
Non-government Company

FAQ - GLAXOSMITHKLINE ASIA PRIVATE LIMITED

What is the incorporation date of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

plus icon

The incorporation date of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is 18 October, 1995

What is the authorized share capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

plus icon

The authorized share capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is INR ₹ 10.0 Cr.

What is the paid-up capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

plus icon

The paid-up capital of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is INR ₹ 5.5 Cr.

What is the registered address of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

plus icon

The registered address of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is Patiala Road Nabha NA Patiala Patiala Punjab - 147201

What is the CIN number of GLAXOSMITHKLINE ASIA PRIVATE LIMITED?

plus icon

The CIN number of GLAXOSMITHKLINE ASIA PRIVATE LIMITED is U99999PB1995PTC028476.

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More